A groundbreaking new method utilizes RFdiffusion and deep learning to design antibodies that target specific epitopes, revolutionizing antibody therapeutics and enhancing their effectiveness against diseases.
A groundbreaking study reveals a new polyvalent recombinant antivenom using just eight VHHs to tackle snake venom, outperforming traditional treatments and offering hope for snakebite victims worldwide.